Company / Cash per Share
Insight Molecular Diagnostics Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.66
FY2025
5-year range
$0.22 / $1.59
FY2021-FY2025
Trend
-36.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 6 years, ranging from $0.13 in FY2020 to $1.59 in FY2023.
Based on SEC 10-K filings.
0.66 in FY2025 with a 5-year CAGR of +39.6%.
Declined from $1.59 to $0.66 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +45.2%
- 5-Year CAGR
- +39.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 36.5% year-over-year.
- Peak cash per share was recorded in FY2023.
- Lowest cash per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.66 | -36.5% |
| FY2024 | $1.05 | -34.3% |
| FY2023 | $1.59 | +633.5% |
| FY2022 | $0.22 | -57.9% |
| FY2021 | $0.52 | +311.3% |
| FY2020 | $0.13 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026